Cara Hatzinger from Rutkowski Lab Receives an F31 Grant to Study the role of TLR5 signaling as a modulator of FLT3 ligand therapeutic efficacy for ovarian cancer
Cara Hatzinger from Rutkowski Lab just received an F31, Investigating the role of TLR5 signaling as a modulator of FLT3 ligand therapeutic efficacy for the treatment of ovarian cancer. Ovarian cancer is the most fatal gynecological malignancy with most patients … Read More









